StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

Investment analysts at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Performance

Shares of Retractable Technologies stock opened at $0.71 on Friday. The company has a quick ratio of 6.54, a current ratio of 9.51 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 52 week low of $0.70 and a 52 week high of $1.34. The firm’s 50 day moving average is $0.81 and its two-hundred day moving average is $0.99. The firm has a market capitalization of $21.26 million, a P/E ratio of -1.16 and a beta of 2.06.

Retractable Technologies (NYSE:RVP) last posted its earnings results on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%. The company had revenue of $6.03 million during the quarter.

Insider Transactions at Retractable Technologies

In other news, CEO Thomas J. Shaw bought 71,422 shares of Retractable Technologies stock in a transaction dated Friday, September 20th. The stock was acquired at an average cost of $0.82 per share, with a total value of $58,566.04. Following the acquisition, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Over the last 90 days, insiders have bought 182,980 shares of company stock worth $153,971. Corporate insiders own 55.00% of the company’s stock.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent filing with the SEC. 7.58% of the stock is currently owned by institutional investors and hedge funds.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.